1.
All the following are directly-acting cholinomimetic agents, except
2.
All the following are pharmacological effects of directly-acting cholinomimetic agents, except
3.
All the following are therapeutic indications of directly-acting cholinomimetic agents, except
4.
All the following are adverse effects of directly-acting cholinomimetic agents, except
5.
All the following are indirectly-acting cholinomimetic agents, except
6.
All the following are pharmacological effects of indirectly-acting cholinomimetic agents, except
7.
All the following are therapeutic indications of indirectly-acting cholinomimetic agents, except
8.
All the following are adverse effects of indirectly-acting cholinomimetic agents, except
9.
Duration of action of acetylcholine
10.
Following is a direct-acting cholinomimetic agent
11.
Side effect associated with systemic cholinomimetics is
12.
Cholinomimetic used in the treatment of glaucoma is
13.
Decrease in cardiac rate and force of contraction is mediated by stimulation of
14.
Enzyme inhibited by indirect-acting cholinomimetics is
15.
Drugs used to stimulate bladder function in patients with urinary retention is
16.
NOT a direct-acting cholinomimetic agent
17.
Cholinesterase inhibitor used in the management of Alzheimer's disease is
18.
Activation of muscarinic receptors causes all the following except
19.
Cholinomimetic used in the management of myasthenia gravis is
20.
Following is a clinical use of neostigmine